Average Co-Inventor Count = 3.60
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (15 from 4,455 patents)
2. Skyhawk Therapeutics, Inc. (11 from 11 patents)
3. Novartis Ag (8 from 3,923 patents)
4. Glaxo Wellcome Inc. (5 from 281 patents)
5. Smithkline Beecham Corporation (4 from 2,198 patents)
6. Glaxo Inc. (2 from 56 patents)
7. Other (1 from 832,843 patents)
8. Biogen Ma Inc. (1 from 250 patents)
9. Agouron Pharmaceuticals, Inc. (1 from 174 patents)
10. Astex Therapeutics Limited (1 from 123 patents)
11. Pfizer Products Inc. (1 from 47 patents)
12. Verastem, Inc. (1 from 12 patents)
13. Edgewise Therapeutics, Inc. (1 from 6 patents)
50 patents:
1. 12448369 - Quinolinone amide compounds and uses thereof
2. 11964971 - Methods and compositions for modulating splicing
3. 11845744 - Methods and compositions for modulating splicing
4. 11603531 - Methods and compositions for modulating splicing
5. 11530207 - Compounds for the treatment of cancer
6. 11505541 - Protein kinase C inhibitors and methods of their use
7. 11434489 - Methods and compositions for modulating splicing
8. 11326165 - Methods and compositions for modulating splicing
9. 11168095 - ASK1 inhibiting agents
10. 11162101 - Methods and compositions for modulating splicing
11. 11129829 - Methods for modulating splicing
12. 11091475 - Methods and compositions for modulating splicing
13. 11059804 - Protein kinase C inhibitors and methods of their use
14. 11021708 - Methods and compositions for modulating splicing
15. 11008572 - Methods and compositions for modulating splicing